The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IMW 2021 | IMW 2021: MRD highlights
Daniel Auclair, PhD, of the Multiple Myeloma Research Foundation (MMRF), Norwalk, CT, gives an overview of the key updates on the use of measurable residual disease (MRD) in myeloma, as presented at the IMW 2021 meeting, and discusses updates and sessions which will take place at the upcoming MMRF MRD Meeting on October 13th. This interview took place during the 18th International Myeloma Workshop (IMW 2021) congress.
